Skip to main content

Table 3 Demographic and surgery variables. Data are mean (SD) or number of dogs (%)

From: Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial

Variable Robenacoxib Meloxicam Total P value*
Number of dogs 118 56 174  
Age (years) 5.9 (3.9) 5.2 (4.1) 5.7 (3.9) 0.20
Body weight (kg) 20.8 (12.3) 19.0 (11.1) 20.2 (11.9) 0.42
Sex and neutered status     
Male not neutered 14 (11.9%) 8 (14.3%) 22 (12.6%) 0.37
Female not neutered 87 (73.7%) 40 (71.4%) 127 (73.0%)
Male neutered 5 (4.2%) 0 (0%) 5 (2.9%)
Female neutered 12 (10.2%) 8 (14.3%) 20 (11.5%)
Pre-surgery pain (VAS)     
 ▪ At rest 2.0 (5.4) 1.7 (2.3) 1.9 (4.6) 0.21
 ▪ At palpation/manipulation 5.2 (10.2) 4.2 (6.3) 4.9 (9.2) 0.64
Type of surgery**     
 ▪ Ovariectomy 37 (31%) 22 (39%) 59 (34%) 0.31
 ▪ Ovario-hysterectomy 28 (24%) 10 (18%) 38 (22%) 0.44
 ▪ Mammary chain excision 30 (25%) 15 (27%) 45 (26%) 0.85
 ▪ Gastro-intestinal surgery 5 (4%) 0 (0%) 5 (3%) 0.18
 ▪ Genito-urinary surgery 5 (4%) 2 (4%) 7 (4%) 1.0
 ▪ Thoracic surgery 1 (1%) 0 (0%) 1 (1%) 1.0
 ▪ Other soft tissue surgery 22 (19%) 10 (18%) 32 (18%) 1.0
Duration of surgery (hours) 0.85 (0.52) 0.68 (0.35) 0.79 (0.48) 0.037
Duration of intubation (hours) 1.4 (0.77) 1.2 (0.60) 1.3 (0.73) 0.20
Time between injection of robenacoxib or meloxicam and extubation (hours) 1.6 (0.81) 1.4 (0.63) 1.5 (0.76) 0.18
Duration of oral dosing (days) 11.3 (22.2) 10.9 (3.0) - 0.92
  1. Data are mean (SD) or number of dogs (%).
  2. * Significance of differences between treatment groups (Kruskal-Wallis or Mann–Whitney U tests).
  3. ** Some dogs underwent two surgeries during the same anesthesia.